RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @Fraslin: Innocuité et efficacité du vaccin ChAdOx1 nCoV-19 (AZD1222) Oxford/AstraZeneca contre le SRAS-CoV-2: une analyse intermédiaire…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Tony_Calles: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised co…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @joserrapa: Publicación (peer-review) del ensayo de la vacuna de Oxford / Astra @TheLancet @MartinQuirosMD
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @AmbrizMau: La vacuna ChAdOx1 nCoV-19 tiene un perfil de seguridad aceptable y se ha encontrado que es eficaz para prevenir la COVID-19…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @gary_lyman: <0.1% were patients with cancer - we do NOT know efficacy of this vaccine in patients with malignant disease and several ot…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @VaccineWatch: AstraZenecaの新型コロナワクチンの臨床試験における有効性データがLancetに掲載されました。学術誌に有効性データが掲載されるのはこれが最初だと思います。投与量の混乱がありましたが、有効性は間違い無くあります。
RT @EricTopol: See @nataliexdean's astute critique thread. Many deficiencies in the data and hard to interpret the low dose story https://t…
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @BhadeliaMD: Couple of interesting things about this Astra Zeneca vaccine data just released. First, they did a substudy in UK where the…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
....
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @StephaneKM: Elles sont fraîches, mes données AstraZeneca, elles sont fraîches !
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
Yayını olan ve kullanılabilecek bir aşımız daha oldu. Bakalım alabilecek miyiz?
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek verildiğinde % 90 etkili ve güvenli!.. Yaş gruplarına göre etkiler ve bağışıklık süresi de incelenecek.👇🏻 https://t.co/nemj1gVplO
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @RonnySuarez_: ¡¡¡SE HACEN PÚBLICOS LOS RESULTADOS DE LA VACUNA DE OXFORD!!! ES SEGURA Y EFICAZ, DICE THE LANCET
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancetInfDis: Just published @TheLancet: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @JesusAmoSerrano: Para los escépticos.
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @MartinQuirosMD: Y aquí el ensayo clínico revisado por pares de la vacuna de Oxford-AstraZeneca. https://t.co/Zf90twDNtN
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
❤️
RT @RonnySuarez_: ¡¡¡SE HACEN PÚBLICOS LOS RESULTADOS DE LA VACUNA DE OXFORD!!! ES SEGURA Y EFICAZ, DICE THE LANCET
RT @MenePangalos: First peer-reviewed publication in @TheLancet of Phase III interim analysis @UniofOxford #COVID19 vaccine https://t.co/ku…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
Excellent review
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
RT @sandyddouglas: Super-proud of our amazing team @JennerInstitute and @OxfordVacGroup , and all our partners😊 @AstraZeneca are committed…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/CrjAzEy1cZ
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @AmbrizMau: La vacuna ChAdOx1 nCoV-19 tiene un perfil de seguridad aceptable y se ha encontrado que es eficaz para prevenir la COVID-19…
RT @covid19indiaorg: 2 important vaccine related readings for those who like a deep dive: 1. Early Phase 3 results of Oxford vaccine publi…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @Karl_Lauterbach: Wenn Ergebnisse mRNA Impfstoffe nicht so überragend wären würden wir Oxford/Astra Impfstoff als Durchbruch feiern. Ich…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @CristinaDragani: The #OxfordVaccine (AZD1222) has an acceptable safety profile and has been found effective against the symptoms of #CO…
RT @EricTopol: Corrected link: https://t.co/jMmFzC99R5
The AstraZeneca COVID-19 vaccine safety and efficacy data published in The Lancet in an interim analysis of four randomised controlled trials https://t.co/PakvXxRl9T #COVID19Vaccine
RT @pandeysantu: This viral vector vaccine, ChAdOx1 nCoV-19, could contribute to control of the disease in this pandemic.
😷🧴📏🤜💉🦠🤛
RT @surzua_chile: La vacuna funciona. Fuente: artículo en The Lancet. https://t.co/t9Uoc8hzh5 https://t.co/gyRR69fwIM
Carece de calidad metodológica óptima. Es lo que hay chicxs. https://t.co/FIDZUPoQoM
RT @irlandamaya: UPDATE!!!: los primeros resultados completos del análisis intermedio confirman que la vacuna de Oxford #COVID19 es segura…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
Ya van a decir que también eso es broma, que es mentira, que mienten que no se qué...
For anyone interested in a deep dive.....
RT @surzua_chile: La vacuna funciona. Fuente: artículo en The Lancet. https://t.co/t9Uoc8hzh5 https://t.co/gyRR69fwIM